Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1961 1
1970 1
1972 1
1976 1
1979 2
1984 1
1987 1
1988 1
1990 1
1991 2
1992 2
1993 2
1994 2
1995 3
1996 2
1997 5
1998 4
1999 4
2000 8
2001 7
2002 4
2003 9
2004 9
2005 11
2006 12
2007 8
2008 14
2009 9
2010 15
2011 28
2012 35
2013 64
2014 65
2015 60
2016 40
2017 38
2018 29
2019 18
2020 18
2021 14
2022 9
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 23790596

519 results

Results by year

Filters applied: . Clear all
Page 1
Updated guidelines on outpatient anticoagulation.
Wigle P, Hein B, Bloomfield HE, Tubb M, Doherty M. Wigle P, et al. Am Fam Physician. 2013 Apr 15;87(8):556-66. Am Fam Physician. 2013. PMID: 23668445 Free article.
[Has the era of warfarin terminated?].
Pavlova TV, Dupliakov DV, Kuzina TN. Pavlova TV, et al. Angiol Sosud Khir. 2014;20(1):16-20. Angiol Sosud Khir. 2014. PMID: 24722016 Russian.
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II]).
Steinberg BA, Simon DN, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients. Steinberg BA, et al. Am J Cardiol. 2017 May 15;119(10):1590-1595. doi: 10.1016/j.amjcard.2017.02.015. Epub 2017 Mar 28. Am J Cardiol. 2017. PMID: 28363354 Free article. Clinical Trial.
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR, Hellkamp AS, Lokhnygina Y, Piccini JP, Zhang Z, Mohanty S, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Becker RC, Nessel CC, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW. Patel MR, et al. J Am Coll Cardiol. 2013 Feb 12;61(6):651-8. doi: 10.1016/j.jacc.2012.09.057. J Am Coll Cardiol. 2013. PMID: 23391196 Free article. Clinical Trial.
Warfarin in non-valvular atrial fibrillation.
Dalby AJ, Wessels P, Opie LH. Dalby AJ, et al. S Afr Med J. 2013 Oct 11;103(12):901-4. doi: 10.7196/samj.7172. S Afr Med J. 2013. PMID: 24300625 Review.
519 results